Seoul Seeks To Expand Biomedical Fund With MOUs Signed With U.S. States Massachusetts And Maryland
This article was originally published in PharmAsia News
Executive Summary
SEOUL - The Seoul Metropolitan Government is pushing to expand its KRW 100 billion ($92.2 million) biomedical fund, established last year by the Boston venture capital firm Oxford Bioscience Partners and Korea's Hanwha Venture Capital to boost Korea's life sciences industries